embecta to Report Fiscal Second Quarter Financial Results
embecta (Nasdaq: EMBC) will report fiscal second quarter 2026 results and host a live conference call and webcast on May 5, 2026 at 8:00 a.m. ET.
Rhea-AI Summary
embecta (Nasdaq: EMBC) will report fiscal second quarter 2026 results and host a live conference call and webcast on May 5, 2026 at 8:00 a.m. ET. A replay will be available beginning at 11:00 a.m. ET on the embecta investor relations website and archived for one year.
Positive
- None.
Negative
- None.
Details
News Market Reaction – EMBC
In the Apr 22 session, EMBC gained 0.88%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings call time
- 8:00 a.m. ET
- Fiscal Q2 2026 conference call on May 5, 2026
- Earnings call date
- May 5, 2026
- Fiscal second quarter 2026 results release and call
- Replay start time
- 11:00 a.m. ET
- Webcast replay availability on May 5, 2026
- Replay duration
- 1 year
- Archive period for webcast replay on investor relations website
Previous Earnings date Reports
-
Announcement of upcoming fiscal Q1 2026 results and investor call logistics.
-
Set date for Q4 and full-year 2025 results and guidance conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, May 5, 2026.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |